Clinical trial
Facebook Intervention for Young Onset Melanoma Patients and Families
NCT03677739 is registered in ClinicalTrials.gov with Rutgers, The State University of New Jersey as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Facebook Intervention for Young Onset Melanoma Patients and Families
- Lead sponsor
- Rutgers, The State University of New Jersey
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- June 3, 2019
- Completion date
- May 31, 2026
- Enrollment
- 1,160 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
clinical stage 0 cutaneous melanoma ajcc v8, clinical stage i cutaneous melanoma ajcc v8, clinical stage ia cutaneous melanoma ajcc v8, clinical stage ib cutaneous melanoma ajcc v8, clinical stage ii cutaneous melanoma ajcc v8, clinical stage iia cutaneous melanoma ajcc v8, clinical stage iib cutaneous melanoma ajcc v8, clinical stage iic cutaneous melanoma ajcc v8, clinical stage iii cutaneous melanoma ajcc v8, first degree relative, pathologic stage 0 cutaneous melanoma ajcc v8, pathologic stage i cutaneous melanoma ajcc v8, pathologic stage ia cutaneous melanoma ajcc v8, pathologic stage ib cutaneous melanoma ajcc v8, pathologic stage ii cutaneous melanoma ajcc v8, pathologic stage iia cutaneous melanoma ajcc v8, pathologic stage iib cutaneous melanoma ajcc v8, pathologic stage iic cutaneous melanoma ajcc v8, pathologic stage iii cutaneous melanoma ajcc v8, pathologic stage iiia cutaneous melanoma ajcc v8, pathologic stage iiib cutaneous melanoma ajcc v8, pathologic stage iiic cutaneous melanoma ajcc v8